dimanche 15 novembre 2026
RechercherExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
Source document· October 20, 2026

Zions projects 8%-12% Q3 2027 net interest income growth while scaling Basis multifamily to $30M-$40M medium-term revenue

View original at seekingalpha.com
“"net earnings available to common was $262 million or $1.78 per share" (Chairman & CEO Harris Simmons)”
Verbatim excerpt from the source · short snapshot: read the full document at the original

Ce que nous avons tiré de cette source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Q3 2027 NII is expected to increase approximately 8%-12%, assuming three rate increases and deposit costs rising to around 2%.

    60% confidence
  • Total cost of deposits increased 11 bps to 1.59%; a presentation change added ~3 bps to reported cost of deposits with no impact on overall cost of funds.

    60% confidence
  • About $2.2 billion of broker deposits mature in Q4; excess money markets can fund loans or reduce broker deposits.

    60% confidence
  • Guidance implies deposit costs up about 40 bps (beta in the upper 40s to low 50s), with NIM scenarios in the mid-3s in 2027.

    60% confidence
  • 2026 operating leverage is now expected at approximately 40-50 bps including Basis, versus 100-150 bps previously; excluding the acquisition it would approach the low end of the prior range.

    60% confidence
  • Over the medium term Basis is expected to generate approximately $30M-$40M of annual revenue; 2027 revenue $17M-$20M and expense $12M-$13M.

    60% confidence
  • Loan growth expected at 2%-4% for Q3 2027 vs Q3 2026; outlook tempered, particularly in commercial real estate.

    60% confidence
  • Buyback actions are subject to regulatory approvals and the Board, but there are scenarios where capital absorption could increase.

    60% confidence
  • Cash-flow hedges are kept under 2 years and rolled on a continuous basis.

    60% confidence
  • Q3 2027 adjusted noninterest expense expected to increase approximately 4%-6%.

    60% confidence
  • CRE showed basically no growth in the quarter (negative $9M), mainly due to Amegy being down; management is not especially worried.

    60% confidence
  • Q3 deposit growth was a little uneven and may not persist at 8.8% annualized; the Basis expense outlook beyond 2027 awaits more experience.

    60% confidence
  • CRE pipeline is pretty good but Zions is being very disciplined in underwriting amid competition and rates.

    60% confidence
  • Q3 2027 adjusted customer-related fee income expected to grow 6%-9% from $182M in Q3 2026.

    60% confidence
  • Expects better Q4 Basis revenue than Q3, and describes the effort as a marathon rather than a sprint.

    60% confidence
  • Analysts commended the new quantitative guidance ranges.

    60% confidence
  • Management is reasonably pleased with Q3 results: net earnings to common $262M or $1.78/share, NIM 3.23%, credit losses 2 bps annualized.

    60% confidence
  • Wealth management is a compelling growth opportunity; Wealth Select expands the addressable market to $100K-$1M investable assets.

    60% confidence
  • Texas M&A disruption is an opportunity for Zions and is viewed as more positive.

    60% confidence
Ce que nous savons · l'intelligence derrière cette page
En direct du substrat
Ce que nous observons
Q4 2026 Biotech Catalyst Cluster: Late-Stage Data and PDUFA Dates Converge
Early-to-mid November 2026 is a dense run of clinical readouts and Q3 earnings at AHA, AASLD, ACR and ASH. Mid-cap biotechs (Vir, Mineralys, Arrowhead, Oryzon, Novartis, J&J) are reporting data that feeds into regulatory decisions. The next ones are the ivonescimab BLA (Nov 14) and the lorundrostat PDUFA (Dec 22), followed by ECLIPSE 2/3 and Maritime-1 readouts in Q1 2027. The list also includes an unrelated delisting track (EGM Nov 19, application Jan 25, 2027), and the facts have no AI or fintech content.
Notre lecture des données ›
Signaux que nous suivons
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Tendances que nous surveillons ›
Là où les sources divergent
Sources réconciliées : aucun conflit ouvert pour l'instant.
Nous signalons les conflits ouvertement ›
Vérifié récemment
✓ Vérifié avec la source d'origine
4,995
faits reliés à leur source, et nous signalons ceux qui ne tiennent pas.
101 entités suivies4,995 faits vérifiés avec la source5,585 documents sources archivés
Interrogez ces données → isubstrate.com
Zions projects 8%-12% Q3 2027 net interest income growth while scaling Basis multifamily to $30M-$40M medium-term revenue: Source | Via News | fr.via.news